LLNM | OR (95% CI, p value) | ||||
---|---|---|---|---|---|
no | yes | univariable | multivariable | ||
Sex | Female | 3565 (97.2) | 103 (2.8) | - | - |
Male | 1150 (95.5) | 54 (4.5) | 1.63 (1.15–2.26, 0.005) | 1.35 (0.94–1.93, 0.102) | |
Age group | ≥ 55 years | 705 (97.4) | 19 (2.6) | - | - |
<55 years | 4010 (96.7) | 138 (3.3) | 1.28 (0.81–2.14, 0.324) | 0.97 (0.60–1.65, 0.903) | |
Tumor upper location | no | 3630 (97.3) | 99 (2.7) | - | - |
yes | 1085 (94.9) | 58 (5.1) | 1.96 (1.40–2.72,0.001) | 2.56 (1.80–3.62,0.001) | |
Tumor size | ≤ 7 mm | 3308 (98.1) | 63 (1.9) | - | - |
>7 mm | 1407 (93.7) | 94 (6.3) | 3.51 (2.54–4.87,0.001) | 2.59 (1.85–3.65,0.001) | |
Hashimoto’s thyroiditis | no | 3661 (96.9) | 118 (3.1) | - | - |
yes | 1054 (96.4) | 39 (3.6) | 1.15 (0.78–1.64, 0.463) | 1.27 (0.85–1.87, 0.224) | |
ETE | no | 2684 (97.7) | 64 (2.3) | - | - |
yes | 2031 (95.6) | 93 (4.4) | 1.92 (1.39–2.66,0.001) | 1.41 (1.01–1.99, 0.044) | |
LVI | no | 4686 (96.8) | 155 (3.2) | - | - |
yes | 29 (93.5) | 2 (6.5) | 2.08 (0.34-7.00, 0.318) | 1.06 (0.16–3.85, 0.939) | |
CLNM | 0 | 2980 (98.4) | 47 (1.6) | - | - |
1–2 | 1142 (95.7) | 51 (4.3) | 2.83 (1.89–4.24,0.001) | 2.91 (1.93–4.42,0.001) | |
≥ 3 | 593 (91.0) | 59 (9.0) | 6.31 (4.26–9.38,0.001) | 5.84 (3.83–8.93,0.001) |